Maribavir for Refractory Cytomegalovirus Infections With or Without Resistance Post-Transplant: Results From a Phase 3 Randomized Clinical TrialRobin K. Avery, Catherine Cordonnier, Rafael F. Duarte et al.|Clinical Infectious Diseases|2021Cited by 299
Donor CMV serologic status and outcome of CMV-seropositive recipients after unrelated donor stem cell transplantation: an EBMT megafile analysisPer Ljungman, Catherine Cordonnier|Blood|2003Cited by 252
Letermovir for Secondary Prophylaxis of Cytomegalovirus Infection and Disease after Allogeneic Hematopoietic Cell Transplantation: Results from the French Compassionate ProgramChristine Robin, Catherine Cordonnier, Anne Thiébaut et al.|Biology of Blood and Marrow Transplantation|2020Cited by 77
Sepsis associated with immunosuppressive medications: An evidence-based reviewJuan Gea‐Banacloche, Catherine Cordonnier, Steven M. Opal et al.|Critical Care Medicine|2004Cited by 62